SPOP and cancer: Among patients with SPOP mutations, 56.3% showed metastasis at the time of diagnosis of primary cancer, compared with only 11.5% of the patients with wild-type SPOP (OR, 6.58, 95% CI, 5.81-7.46, P = 0.000) (Table 2).